Redfield Robert
SEC insider (Form 3/4/5 filer). CIK 0002018274. Chief Medical Officer at Traws Pharma, Inc. (TRAW). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in NEWTOWN, PA.
Companies Redfield Robert has filed insider reports for
- Traws Pharma, Inc. (TRAW): Officer, Chief Medical Officer
Redfield Robert
CIK: 0002018274
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TRAW
Traws Pharma, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 9, 2026TRAW
Traws Pharma, Inc.
AwardDirectStock Option (right to buy)
84K shares- - Mar 8, 2026TRAW
Traws Pharma, Inc.
AwardDirectStock Option (right to buy)
108.9K shares- - Dec 12, 2025TRAW
Traws Pharma, Inc.
AwardDirect16.4K shares- - Oct 12, 2025TRAW
Traws Pharma, Inc.
AwardDirectStock Option (right to purchase)
32.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 | TRAW Traws Pharma, Inc. | Award Stock Option (right to buy) | 84,000 | - | - | Direct |
| Mar 8, 2026 | TRAW Traws Pharma, Inc. | Award Stock Option (right to buy) | 108,854 | - | - | Direct |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | Award | 16,419 | - | - | Direct |
| Oct 12, 2025 | TRAW Traws Pharma, Inc. | Award Stock Option (right to purchase) | 32,406 | - | - | Direct |
1-4 of 4 transactions